Other Name(s): Thioredoxin, Txn, SASP, Trx1
Assay:Inhibition of human recombinant TRX-1 up to 60 mins by insulin reduction assay
Type:Ki
SMILES:CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O
Value:=3110nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:Nn1c(SSC2CCCCC2)nnc1-c1ccccc1
Value:=540nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:c1ccc(-c2cnc(SSC3CCCCC3)[nH]2)cc1
Value:=450nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:Nc1nc(O)c2[nH]c(SSC3CCCCC3)nc2n1
Value:=290nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:O=C(c1ccccc1)c1ccc2nc(SSC3CCCCC3)[nH]c2c1
Value:=240nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:O=[N+]([O-])c1ccc2nc(SSC3CCCCC3)[nH]c2c1
Value:=90nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:Fc1cc2nc(SSC3CCCCC3)[nH]c2cc1Cl
Value:=170nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:c1ccc2sc(SSC3CCCCC3)nc2c1
Value:=510nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:CC(C)(C)SSc1nc2ccccc2[nH]1
Value:=7310nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:CCSSc1nc2ccccc2[nH]1
Value:=340nM
Source:Homo sapiens
Assay:Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis
Type:IC50
SMILES:CCC(C)SSc1ncc[nH]1
Value:=2110nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CCOC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)cc2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:O=C(Nc1ccccc1)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:O=C(NC1CCCC1)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CCN(C)C(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CC(C)(C)OC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CC(C)OC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CCOC(=O)C1(CCOc2ccccc2)CCN(C(=O)c2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CCOC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(OC)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens
Assay:Inhibition of TR (unknown origin) assessed as reduction in enzyme-mediated bovine insulin aggregation after 30 mins by turbidimetric assay
Type:IC50
SMILES:CCOC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1
Value:>30000nM
Source:Homo sapiens

Note: If you'd like to learn how our AI-powered BDE-Chem can help design therapeutic molecules against the TXN target, that break through the existing patents, at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai

Molecules for More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BRAF | BRCA1 | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CDKN1A | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA5 | IDO1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SRC | STAT1 | STAT3 | STAT5A | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1